Exact Sciences Corp.
American company in Madison, United States / From Wikipedia, the free encyclopedia
This article is about an American bioscience company. For the branch of sciences, see Exact sciences.
Exact Sciences Corp. is a molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown its product portfolio to encompass other screening and precision oncological tests for other types of cancer.[3]
Quick Facts Company type, Traded as ...
Company type | Public |
---|---|
| |
Industry | Molecular diagnostics |
Founded | 1995; 29 years ago (1995) in Marlborough, Massachusetts |
Founders |
|
Headquarters | Madison, Wisconsin, U.S. |
Key people | |
Products | Cologuard, Oncotype DX, Oncotype MAP |
Revenue | US$2.50 billion (2023) |
US$−215 million (2023) | |
US$−204 million (2023) | |
Total assets | US$6.47 billion (2023) |
Total equity | US$3.15 billion (2023) |
Number of employees | 6,500 (Dec 2023) |
Subsidiaries | Subsidiary List
|
Website | exactsciences |
Footnotes / references [1][2] |
Close